Diclazepam

Diazepam is a benzodiazepine drug that produces psychoactive effects by enhancing signaling through the γ-aminobutyric acid (GABA) receptor GABAA. Diclazepam is a 2’-chloro derivative of diazepam that has emerged as a designer drug. It is metabolized in vivo into the pharmacologically active benzodiazepines delorazepam, lorazepam, and lormetazepam, which can be detected in urine for 6, 19, and 11 days, respectively. The product is intended for forensic and research applications.